STOCK TITAN

Ingersoll Rand Reports Record Second Quarter 2024 Revenue, Adjusted EBITDA, and Adjusted EPS Performance

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Ingersoll Rand (NYSE: IR) reported record second quarter 2024 results, with revenues of $1,805 million (up 7% YoY), adjusted EBITDA of $495 million (up 16% YoY), and adjusted EPS of $0.83. The company is raising its full-year 2024 guidance, projecting total revenue growth of 6-8%, adjusted EBITDA of $2,010-$2,060 million (up 12-15% YoY), and adjusted EPS of $3.27-$3.37 (up 10-14% YoY). Strong performance was driven by pricing strength and operational execution through the Ingersoll Rand Execution Excellence (IRX) model. The company maintains a solid financial position with $3.7 billion in liquidity and completed multiple acquisitions in Q2, including ILC Dover for $2.6 billion.

Ingersoll Rand (NYSE: IR) ha riportato risultati record per il secondo trimestre del 2024, con ricavi di $1.805 milioni (in crescita del 7% su base annua), un EBITDA rettificato di $495 milioni (in crescita del 16% su base annua) e un EPS rettificato di $0,83. L'azienda sta innalzando le previsioni per l'intero anno 2024, prevedendo una crescita dei ricavi totali del 6-8%, un EBITDA rettificato di $2.010-$2.060 milioni (in crescita del 12-15% su base annua) e un EPS rettificato di $3,27-$3,37 (in crescita del 10-14% su base annua). Le performance solide sono state trainate dalla forza dei prezzi e dall'esecuzione operativa attraverso il modello di Eccellenza Operativa di Ingersoll Rand (IRX). L'azienda mantiene una posizione finanziaria solida con $3,7 miliardi in liquidità e ha completato diverse acquisizioni nel secondo trimestre, tra cui ILC Dover per $2,6 miliardi.

Ingersoll Rand (NYSE: IR) reportó resultados récord para el segundo trimestre de 2024, con ingresos de $1,805 millones (un aumento del 7% interanual), EBITDA ajustado de $495 millones (un aumento del 16% interanual) y EPS ajustado de $0.83. La empresa está elevando sus proyecciones para todo el año 2024, proyectando un crecimiento total de ingresos del 6-8%, EBITDA ajustado de $2,010-$2,060 millones (un aumento del 12-15% interanual) y un EPS ajustado de $3.27-$3.37 (un aumento del 10-14% interanual). Un rendimiento sólido fue impulsado por la fortaleza de precios y la ejecución operativa a través del modelo de Excelencia Operativa de Ingersoll Rand (IRX). La compañía mantiene una posición financiera sólida con $3.7 mil millones en liquidez y completó múltiples adquisiciones en el segundo trimestre, incluyendo a ILC Dover por $2.6 mil millones.

인거솔 랜드 (NYSE: IR)는 2024년 2분기 기록적인 실적을 발표했습니다. 매출은 18억 5천만 달러(전년 대비 7% 증가), 조정 EBITDA는 4억 9천 5백만 달러(전년 대비 16% 증가), 조정 EPS는 0.83달러입니다. 회사는 2024년 전체 연도 가이던스를 상향 조정하고 있습니다. 총 매출 성장률은 6-8%로 예상하며, 조정 EBITDA는 20억 1천만 달러에서 20억 6천만 달러(전년 대비 12-15% 증가) 및 조정 EPS는 3.27달러에서 3.37달러(전년 대비 10-14% 증가)로 예상합니다. 강력한 성과는 가격 강세와 인거솔 랜드의 실행 우수성(IRX) 모델을 통한 운영 실행으로 인해 이루어졌습니다. 회사는 37억 달러의 유동성을 가지고 있으며, 2분기 동안 ILC Dover를 26억 달러에 인수하는 등 여러 인수를 완료했습니다.

Ingersoll Rand (NYSE: IR) a annoncé des résultats records pour le deuxième trimestre 2024, avec des revenus de 1,805 milliard de dollars (en hausse de 7 % par rapport à l'année précédente), un EBITDA ajusté de 495 millions de dollars (en hausse de 16 % par rapport à l'année précédente) et un BPA ajusté de 0,83 dollar. L'entreprise rehausse ses prévisions pour l'année 2024, projetant une croissance des revenus totaux de 6 à 8 %, un EBITDA ajusté de 2,010 à 2,060 milliards de dollars (en hausse de 12 à 15 % par rapport à l'année précédente) et un BPA ajusté de 3,27 à 3,37 dollars (en hausse de 10 à 14 % par rapport à l'année précédente). La solide performance a été soutenue par la force des prix et l'exécution opérationnelle à travers le modèle d'Excellence d'Exécution d'Ingersoll Rand (IRX). L'entreprise maintient une position financière solide avec 3,7 milliards de dollars de liquidités et a réalisé plusieurs acquisitions au deuxième trimestre, notamment celle d'ILC Dover pour 2,6 milliards de dollars.

Ingersoll Rand (NYSE: IR) hat Rekordzahlen für das zweite Quartal 2024 bekannt gegeben, mit Einnahmen von 1.805 Millionen USD (ein Anstieg von 7 % im Jahresvergleich), einem bereinigten EBITDA von 495 Millionen USD (ein Anstieg von 16 % im Jahresvergleich) und einem bereinigten EPS von 0,83 USD. Das Unternehmen erhöht die Prognose für das Gesamtjahr 2024 und rechnet mit einem Umsatzwachstum von 6-8 %, einem bereinigten EBITDA von 2.010 bis 2.060 Millionen USD (ein Anstieg von 12-15 % im Jahresvergleich) und einem bereinigten EPS von 3,27 bis 3,37 USD (ein Anstieg von 10-14 % im Jahresvergleich). Die starke Leistung wurde durch Preiskraft und operationale Ausführung durch das E Excellence-Modell von Ingersoll Rand (IRX) vorangetrieben. Das Unternehmen hält eine solide Finanzlage mit 3,7 Milliarden USD an Liquidität und hat im zweiten Quartal mehrere Akquisitionen abgeschlossen, einschließlich ILC Dover für 2,6 Milliarden USD.

Positive
  • Record Q2 2024 revenue of $1,805 million, up 7% year-over-year
  • Adjusted EBITDA increased 16% to $495 million with margin expansion of 220 basis points
  • Adjusted EPS grew to $0.83, up from the previous year
  • Free cash flow increased 39% to $283 million
  • Raised full-year 2024 guidance for revenue, Adjusted EBITDA, and Adjusted EPS
  • Completed strategic acquisitions, including ILC Dover, to expand market presence
  • Improved debt structure with $3.3 billion investment grade bond issuance
  • Maintained strong liquidity position of $3.7 billion
Negative
  • Organic orders declined 1% year-over-year
  • Net debt to Adjusted EBITDA leverage increased to 2.0x, up 1.0x from prior year
  • Reduced organic growth expectations, particularly in China market

Insights

Ingersoll Rand's Q2 2024 results demonstrate strong financial performance and positive momentum. The company reported record revenue of $1,805 million, up 7% year-over-year, with organic growth of 1%. Notably, Adjusted EBITDA increased by 16% to $495 million, with a margin expansion of 220 basis points to 27.4%.

The company's focus on operational excellence through its IRX (Ingersoll Rand Execution Excellence) model is yielding results, as evidenced by the 250 basis point improvement in gross margin. This efficiency is translating into stronger cash flow, with free cash flow up 39% to $283 million.

Ingersoll Rand's balance sheet remains robust, with $3.7 billion in liquidity. The company's recent upgrade to investment grade status and successful $3.3 billion bond issuance have improved its debt profile, extending the weighted average maturity from 6 to 10 years.

The raised guidance for 2024 is particularly encouraging. The company now expects total revenue growth of 6-8%, Adjusted EBITDA of $2,010-$2,060 million (up 12-15% YoY) and Adjusted EPS of $3.27-$3.37 (up 10-14% YoY). This upward revision, despite macroeconomic headwinds, suggests management's confidence in the company's strategic direction and execution capabilities.

Ingersoll Rand's Q2 2024 results reveal interesting market dynamics. The company's organic order growth was mixed across segments, reflecting varied market conditions. In the Industrial Technologies and Services (IT&S) segment, organic orders declined 3%, primarily due to headwinds in China, particularly in electric vehicle (EV) battery and solar end markets. This suggests potential softening in these high-growth sectors, which investors should monitor closely.

However, the core compressor business showed resilience, with orders up low-single-digits and revenue up mid-single digits. This indicates stable demand in traditional industrial markets. The Precision and Science Technologies (P&ST) segment saw strong organic order growth in both Life Sciences and Industrial businesses, with short-cycle orders growing mid-single digits. This points to robust demand in specialized, high-value markets.

The company's strategic acquisitions, including ILC Dover, Complete Air and Power Solutions, Fruvac and Del PD Pumps & Gear, are expanding its footprint in key markets such as biopharma, pharma and specialized industrial applications. This M&A activity, totaling $2.6 billion in Q2, demonstrates Ingersoll Rand's commitment to diversifying its portfolio and entering high-growth, sustainable end markets.

While the company has reduced its organic growth expectations for 2024, largely due to China, the overall guidance raise suggests that Ingersoll Rand's diversified portfolio and strategic initiatives are offsetting regional challenges. This balanced approach may provide some insulation against market volatility.

Raises Guidance for Total Company Revenue, Adjusted EBITDA, and Adjusted EPS

Second Quarter 2024 Highlights

(All comparisons against the second quarter of 2023 unless otherwise noted.)

Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX):

  • Second quarter orders of $1,799 million, up 4%, or down 1% organic
    • On a two-year stack, up 12%, or up 3% organic
  • Reported second quarter revenues of $1,805 million, up 7%, or up 1% organic1
    • On a two-year stack, up 24%, or up 13% organic1
  • Reported net income attributable to Ingersoll Rand Inc. of $185 million, or earnings of $0.45 per share
    • Adjusted net income1 of $341 million, or $0.83 per share
  • Adjusted EBITDA1 of $495 million, up 16%, with a margin of 27.4%, up 220 basis points year over year
    • Gross Margin improvement of 250 basis points
  • Reported operating cash flow of $305 million and free cash flow1 of $283 million, up 39%
  • Liquidity of $3.7 billion as of June 30, 2024, including $1.1 billion of cash on hand and undrawn capacity of $2.6 billion under available credit facilities
  • Backlog remains near historically high levels, up 3% with a book to bill of 1.0x for the second quarter and a book to bill of 1.01x for the first half of 2024

Raising 2024 Guidance

  • Raising total revenue growth guidance to a range of 6% to 8% for the full year
  • Raising Adjusted EBITDA1 guidance to a range of $2,010 to $2,060 million, up 12% to 15% over prior year
  • Raising full-year 2024 Adjusted EPS1 guidance to a range of $3.27 to $3.37, up 10% to 14% over prior year

DAVIDSON, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR) reported record second quarter revenues, Adjusted EBITDA, and Adjusted EPS.

“Our results demonstrate that Ingersoll Rand continues to expand into durable, high-growth, sustainable end markets,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “Despite the headwinds in the macroeconomic environment, we are raising our guidance on revenue, Adjusted EBITDA, and Adjusted EPS following a solid performance this quarter. We remain confident that our IRX execution model will continue to drive long-term value creation.”

Second Quarter 2024 Segment Review

(All comparisons against the second quarter of 2023 unless otherwise noted.)

Industrial Technologies and Services Segment (IT&S): broad range of compressor, vacuum, blower, and air treatment solutions as well as industrial technologies including power tools and lifting equipment

  • Reported Orders of $1,465 million, up 1%, or down 3% organic
    • On a two-year stack, up 14%, or up 6% organic
    • Book to bill of 1.0x in the quarter and 1.01x in the first half of 2024
    • Up 5% sequentially as compared to Q1 2024
  • Reported Revenues of $1,467 million, up 6%, or up 1% organic1
  • Reported Segment Adjusted EBITDA of $436 million, up 16%
  • Reported Segment Adjusted EBITDA Margin of 29.7%, up 230 basis points, due to continued pricing strength and IRX driving strong operational execution
  • IT&S saw organic orders finish largely in line with expectations, down 3%, mainly due to China market headwinds including large, long-cycle orders taken in the prior year in electric vehicle (EV) battery and solar end markets. Within compressors, orders were up low-single-digits and revenue was up mid-single digits2. Book to bill remains on track and consistent with the previous guidance, finishing above 1.0x in the first half of the year.

Precision and Science Technologies Segment (P&ST): Mission-critical precision liquid, gas, air and powder handling technologies for life sciences, industrial, and aerospace and defense applications

  • Reported Orders of $334 million, up 14%, or up 6% organic
    • On a two-year stack, up 6%, or down 4% organic
    • Book to bill of 0.99x in the quarter and 1.01x in the first half of 2024
  • Reported Revenues of $339 million, up 10%, or down 1% organic1
  • Reported Segment Adjusted EBITDA of $103 million, up 14%
  • Reported Segment Adjusted EBITDA Margin of 30.3%, up 110 basis points, driven largely by improvements in pricing versus cost and strong operational execution driven by IRX
  • Organic order growth was strong across both Life Sciences and the Industrial businesses. In the Industrial businesses, short cycle orders grew mid-single digits year over year, driven by demand generation activities and the use of IRX.

Balance Sheet and Cash Flow

Ingersoll Rand remains in a strong financial position with ample liquidity of $3.7 billion. On a reported basis, the Company generated $305 million of cash flow from operating activities and invested $22 million in capital expenditures, resulting in free cash flow1 of $283 million, compared to cash flow from operating activities of $228 million and free cash flow1 of $204 million in the prior year period. Net debt to Adjusted EBITDA leverage3 was 2.0x for the second quarter, which was an increase of 1.0x as compared to the prior year driven primarily by the acquisition of ILC Dover within the quarter.

The Company received a one notch upgrade from each of its rating agencies, solidifying its investment grade status. In May 2024, the Company issued $3.3 billion of unsecured investment grade bonds. Proceeds of the bond issuance were used to repay $1.2 billion of floating rate secured term loans, $2.0 billion to partially fund the acquisition of ILC Dover, and $0.1 billion for general corporate purposes. Under this new debt structure, Ingersoll Rand achieved a fixed / floating ratio of 84% / 16% and extended its weighted average maturity from six to ten years.

Consistent with our comprehensive capital allocation strategy led by M&A, in the second quarter of 2024, Ingersoll Rand deployed $2.6 billion to M&A. Ingersoll Rand closed on multiple acquisitions within the quarter, including:

  • ILC Dover, a specialized manufacturer of innovative market leading powder management single-use solutions and liquid handling products, for biopharma and pharma markets, and specialty solutions for the design and production of silicone, thermoplastic components and assemblies for medical devices.
  • Complete Air and Power Solutions, a leading provider of compressed air and power generation services with a strong customer base for over 40 years.
  • Fruvac Ltd., a leading manufacturer of mobile and truck mounted vacuum pumps, systems, and peripheral parts.
  • Del PD Pumps & Gear Pvt Ltd., a leading manufacturer of rotary, twin, and triple gear pumps for the loading, unloading, transfer, and pressurization of liquids.

The Company also returned approximately $71 million to shareholders through $63 million in share repurchases and $8 million through its quarterly dividend payment in the second quarter.

____________________
1 Non-GAAP measure (definitions and/or reconciliations in tables below)
2 Excludes the impact of FX and the acquisition of Roots. Compressors include oil lubricated, oil free, reciprocating, and centrifugal offerings.
3 Calculated as Net Debt to LTM Adjusted EBITDA

Raising 2024 Guidance
Ingersoll Rand is raising its guidance for full-year 2024 Revenue, Adjusted EBITDA, and Adjusted EPS ranges based on the strong performance in the first half, and its expectations of continued strong commercial and operational performance for the balance of the year. The full-year revenue guidance increase is driven by the recent M&A activity, partially offset by FX and a reduction in organic growth expectations, largely driven by China.

 Key Metrics
 Previous Guidance
as of 5/2/24
Revised Guidance
as of 7/31/24
Revenue - Total Ingersoll Rand24-6%6-8%
Ingersoll Rand (Organic)12-4%0-2%
Industrial Technologies & Services (Organic)2-4%0-2%
Precision & Science Technologies (Organic)2-4%0-2%
FX Impact3~Flat(~1%)
M&A4~$170M~$440M
Corporate Costs(~$170M)(~$170M)
Adjusted EBITDA1$1,940M - $2,000M
(+9% - +12% YoY)
$2,010M - $2,060M
(+12% - +15% YoY)
Adjusted EPS1$3.20 - $3.30
(+8% - +11% YoY)
$3.27 - $3.37
(+10% - +14% YoY)


Reconciliations of non-GAAP measures related to full-year 2024 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

__________________________________________

1 Non-GAAP measure (definitions and/or reconciliations in tables below)
2 All revenue outlook commentary expressed in percentages and based on growth as compared to 2023
3 Based on June 2024 FX rates; does not include impact of FX on M&A
4 Reflects all completed and closed M&A as of July 31, 2024

Conference Call

Ingersoll Rand will host a live earnings conference call to discuss the second quarter results on Thursday, August 1, 2024 at 8:00 a.m. (Eastern Time). To participate in the call, please dial 1-888-330-3073, domestically, or 1-646-960-0683, internationally, and use access Code 8970061. A real-time audio webcast of the presentation can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website (https://investors.irco.com), where related materials will be posted prior to the conference call. A replay of the webcast will be available after conclusion of the conference and can be accessed on the Ingersoll Rand Investor Relations website.

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Ingersoll Rand Inc.’s (the “Company” or “Ingersoll Rand”) expectations regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.

These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to natural disaster, catastrophe, global pandemics, geopolitical tensions, cyber events, or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive.

Any forward-looking statements speak only as of the date of this release. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

About Ingersoll Rand Inc.

Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life sciences and industrial solutions. Supported by over 80+ respected brands, our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency. For more information, visit www.IRCO.com.

Non-U.S. GAAP Measures of Financial Performance

In addition to consolidated GAAP financial measures, Ingersoll Rand reviews various non-GAAP financial measures, including “Organic Revenue Growth/(Decline),” “Two-Year Stack (for Organic Revenue Growth/(Decline)),” “Adjusted EBITDA,” “Adjusted EBITDA margin,” “Adjusted Net Income,” “Adjusted Diluted EPS” and “Free Cash Flow.”

Ingersoll Rand believes Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, and Adjusted Diluted EPS are helpful supplemental measures to assist management and investors in evaluating the Company’s operating results as they exclude certain items that are unusual in nature or whose fluctuation from period to period do not necessarily correspond to changes in the operations of Ingersoll Rand’s business. Ingersoll Rand believes Organic Revenue Growth/(Decline) and Two-Year Stack (for Organic Revenue Growth/(Decline)) are helpful supplemental measure to assist management and investors in evaluating the Company’s operating results as it excludes the impact of foreign currency and acquisitions on revenue growth. Adjusted EBITDA represents net income before interest, taxes, depreciation, amortization and certain non-cash, non-recurring and other adjustment items. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Revenue. Adjusted Net Income is defined as net income including interest, depreciation and amortization of non-acquisition related intangible assets and excluding other items used to calculate Adjusted EBITDA and further adjusted for the tax effect of these exclusions. Organic Revenue Growth/(Decline) is defined as As Reported Revenue growth less the impacts of Foreign Currency and Acquisitions. Two-Year Stack with respect to Organic Revenue is defined as the sum of current year and prior year Organic Revenue Growth/(Decline). Ingersoll Rand believes that the adjustments applied in presenting Adjusted EBITDA and Adjusted Net Income are appropriate to provide additional information to investors about certain material non-cash items and about non-recurring items that the Company does not expect to continue at the same level in the future. Adjusted Diluted EPS is defined as Adjusted Net Income divided by Adjusted Diluted Average Shares Outstanding. Incrementals/Decrementals are defined as the change in Adjusted EBITDA versus the prior year period divided by the change in revenue versus the prior year period.

Ingersoll Rand uses Free Cash Flow to review the liquidity of its operations. Ingersoll Rand measures Free Cash Flow as cash flows from operating activities less capital expenditures. Ingersoll Rand believes Free Cash Flow is a useful supplemental financial measures for management and investors in assessing the Company’s ability to pursue business opportunities and investments and to service its debt. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities.

Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to, and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition, Ingersoll Rand believes that Organic Revenue Growth/(Decline), Two-Year Stack (for Organic Revenue Growth/(Decline)), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Incrementals/Decrementals and Free Cash Flow are frequently used by investors and other interested parties in the evaluation of issuers, many of which also present Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, and Free Cash Flow when reporting their results in an effort to facilitate an understanding of their operating and financial results and liquidity.

Organic Revenue Growth/(Decline), Two-Year Stack (for Organic Revenue Growth/(Decline)), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow should not be considered as alternatives to revenue growth, net income, diluted earnings per share or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Organic Revenue Growth/(Decline), Two-Year Stack (for Organic Revenue Growth/(Decline)), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing Ingersoll Rand’s results as reported under GAAP.

Reconciliations of Organic Revenue Growth/(Decline), Two-Year Stack (for Organic Revenue Growth/(Decline)), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS and Free Cash Flow to their most comparable U.S. GAAP financial metrics for historical periods are presented in the tables below.

Reconciliations of non-GAAP measures related to full-year 2024 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

Contacts: 
Investor Relations:Media:
Matthew FortSara Hassell
Matthew.Fort@irco.comSara.Hassell@irco.com



INGERSOLL RAND INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited; in millions, except per share amounts)
 For the Three Month Period
Ended June 30,
 For the Six Month Period
Ended June 30,
  2024   2023   2024   2023 
Revenues$1,805.3  $1,686.5  $3,475.4  $3,315.8 
Cost of sales 1,012.0   989.0   1,935.8   1,954.1 
Gross Profit 793.3   697.5   1,539.6   1,361.7 
Selling and administrative expenses 342.1   315.6   678.4   626.7 
Amortization of intangible assets 91.2   89.7   182.8   182.1 
Other operating expense, net 88.2   19.8   113.4   40.2 
Operating Income 271.8   272.4   565.0   512.7 
Interest expense 50.8   40.8   87.6   79.7 
Loss on extinguishment of debt 3.0   0.9   3.0   0.9 
Other income, net (18.1)  (8.2)  (31.3)  (17.8)
Income Before Income Taxes 236.1   238.9   505.7   449.9 
Provision for income taxes 46.1   60.5   100.5   108.6 
Income (loss) on equity method investments (3.5)  2.4   (14.2)  2.7 
Net Income 186.5   180.8   391.0   344.0 
Less: Net income attributable to noncontrolling interests 1.5   1.3   3.8   3.4 
Net Income Attributable to Ingersoll Rand Inc.$185.0  $179.5  $387.2  $340.6 
        
Basic earnings per share 0.46   0.44   0.96   0.84 
Diluted earnings per share 0.45   0.44   0.95   0.83 


INGERSOLL RAND INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited; in millions, except share amounts)

 June 30,
2024
 December 31,
2023
Assets   
Current assets:   
Cash and cash equivalents$1,062.5  $1,595.5 
Accounts receivable, net of allowance for credit losses of $56.9 and $53.8, respectively 1,301.4   1,234.2 
Inventories 1,160.0   1,001.1 
Other current assets 319.3   219.6 
Total current assets 3,843.2   4,050.4 
Property, plant and equipment, net of accumulated depreciation of $535.0 and $500.8, respectively 830.0   711.4 
Goodwill 8,217.1   6,609.7 
Other intangible assets, net 4,478.2   3,611.1 
Deferred tax assets 29.6   31.5 
Other assets 440.4   549.4 
Total assets$17,838.5  $15,563.5 
Liabilities and Stockholders' Equity   
Current liabilities:   
Short-term borrowings and current maturities of long-term debt$4.5  $30.6 
Accounts payable 748.5   801.2 
Accrued liabilities 1,011.6   995.5 
Total current liabilities 1,764.6   1,827.3 
Long-term debt, less current maturities 4,750.9   2,693.0 
Pensions and other postretirement benefits 150.9   150.0 
Deferred income tax liabilities 838.2   612.6 
Other liabilities 309.7   433.9 
Total liabilities$7,814.3  $5,716.8 
Stockholders' equity:   
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 430,371,281 and 428,589,061 shares issued as of June 30, 2024 and December 31, 2023, respectively 4.3   4.3 
Capital in excess of par value 9,595.3   9,550.8 
Retained earnings 2,068.3   1,697.2 
Accumulated other comprehensive loss (340.1)  (227.6)
Treasury stock at cost; 26,595,683 and 25,241,667 shares as of June 30, 2024 and December 31, 2023, respectively (1,369.6)  (1,240.9)
Total Ingersoll Rand stockholders' equity$9,958.2  $9,783.8 
Noncontrolling interests 66.0   62.9 
Total stockholders' equity$10,024.2  $9,846.7 
Total liabilities and stockholders' equity$17,838.5  $15,563.5 


INGERSOLL RAND INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; in millions)

 Six Month Period Ended
June 30,
  2024   2023 
Cash Flows From Operating Activities:  
Net income$391.0  $344.0 
Adjustments to reconcile net income to net cash provided by operating activities:   
Amortization of intangible assets 182.8   182.1 
Depreciation 51.3   43.7 
Non-cash restructuring charges    1.9 
Stock-based compensation expense 28.6   24.0 
Income (loss) on equity method investments 14.2   (2.7)
Foreign currency transaction gains, net (0.7)  (0.1)
Non-cash adjustments to carrying value of LIFO inventories 7.2   14.3 
Loss on extinguishment of debt 3.0   0.9 
Loss on sale of asbestos-related assets and liabilities 33.7    
Other non-cash adjustments 3.4   5.2 
Changes in assets and liabilities:   
Receivables (8.1)  (62.7)
Inventories (63.6)  (29.6)
Accounts payable (72.8)  (126.8)
Accrued liabilities (44.3)  53.1 
Other assets and liabilities, net (59.2)  (48.6)
Net cash provided by operating activities 466.5   398.7 
Cash Flows Used In Investing Activities:   
Capital expenditures (84.1)  (47.2)
Net cash paid in acquisitions (2,744.0)  (615.8)
Disposals of property, plant and equipment    7.3 
Other investing (6.0)  0.3 
Net cash used in investing activities (2,834.1)  (655.4)
Cash Flows From (Used In) Financing Activities:   
Principal payments on long-term debt (1,240.7)  (20.6)
Proceeds from long-term debt 3,296.9    
Purchases of treasury stock (135.5)  (132.8)
Cash dividends on common shares (16.1)  (16.2)
Proceeds from stock option exercises 22.7   15.6 
Payments to settle cross-currency swaps (19.9)   
Payments of deferred and contingent acquisition consideration (12.0)  (5.3)
Payments of debt issuance costs (32.3)  (5.3)
Other financing (1.1)  (1.1)
Net cash provided by (used in) financing activities 1,862.0   (165.7)
Effect of exchange rate changes on cash and cash equivalents (27.4)  (12.5)
Net decrease in cash and cash equivalents (533.0)  (434.9)
Cash and cash equivalents, beginning of period 1,595.5   1,613.0 
Cash and cash equivalents, end of period$1,062.5  $1,178.1 


INGERSOLL RAND INC. AND SUBSIDIARIES
UNAUDITED ADJUSTED FINANCIAL INFORMATION
(Dollars in millions)

 For the Three Month Period
Ended June 30,
 For the Six Month Period
Ended June 30,
  2024   2023   2024   2023 
Ingersoll Rand       
Revenues$1,805.3  $1,686.5  $3,475.4  $3,315.8 
Adjusted EBITDA$494.6  $424.7  $953.1  $824.8 
Adjusted EBITDA Margin 27.4%  25.2%  27.4%  24.9%


INGERSOLL RAND INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME AND ADJUSTED NET INCOME ATTRIBUTABLE TO INGERSOLL RAND AND ADJUSTED DILUTED EARNINGS PER SHARE
(Unaudited; in millions)

 For the Three Month Period
Ended June 30,
 For the Six Month Period
Ended June 30,
  2024   2023   2024   2023 
Net Income$186.5  $180.8  $391.0  $344.0 
Plus:       
Provision for income taxes 46.1   60.5   100.5   108.6 
Amortization of acquisition related intangible assets 89.1   87.1   178.6   176.9 
Restructuring and related business transformation costs 3.9   5.9   14.6   10.2 
Acquisition and other transaction related expenses and non-cash charges 27.7   13.8   43.0   31.8 
Stock-based compensation 14.5   11.9   28.6   24.0 
Foreign currency transaction gains, net    (1.1)  (0.7)  (0.1)
Loss (income) on equity method investments 3.5   (2.4)  14.2   (2.7)
Loss on extinguishment of debt 3.0   0.9   3.0   0.9 
Adjustments to LIFO inventories 0.4   6.5   7.2   14.3 
Cybersecurity incident costs (0.1)  2.2   0.5   2.2 
Loss on asbestos sale 58.8      58.8    
Other adjustments       0.4   (1.4)
Minus:       
Income tax provision, as adjusted 92.3   87.9   178.7   163.5 
Adjusted Net Income 341.1   278.2   661.0   545.2 
Less: Net income attributable to noncontrolling interest 1.5   1.3   3.8   3.4 
Adjusted Net Income Attributable to Ingersoll Rand Inc.$339.6  $276.9  $657.2  $541.8 
        
Adjusted Basic Earnings Per Share1$0.84  $0.68  $1.63  $1.34 
Adjusted Diluted Earnings Per Share2$0.83  $0.68  $1.61  $1.33 
        
Average shares outstanding:       
Basic, as reported 403.5   404.5   403.5   404.8 
Diluted, as reported 407.4   408.3   407.7   408.8 
Adjusted diluted2 407.4   408.3   407.7   408.8 

1 Basic and diluted earnings (loss) per share (as reported) are calculated by dividing net income (loss) attributable to Ingersoll Rand Inc. by the basic and diluted average shares outstanding for the respective periods.
2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding.


INGERSOLL RAND INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited; in millions)

 For the Three Month Period
Ended June 30,
 For the Six Month Period
Ended June 30,
  2024   2023   2024   2023 
Net Income$186.5  $180.8  $391.0  $344.0 
Plus:       
Interest expense 50.8   40.8   87.6   79.7 
Provision for income taxes 46.1   60.5   100.5   108.6 
Depreciation expense 24.6   21.3   49.3   42.0 
Amortization expense 91.2   89.7   182.8   182.1 
Restructuring and related business transformation costs 3.9   5.9   14.6   10.2 
Acquisition and other transaction related expenses and non-cash charges 27.7   13.8   43.0   31.8 
Stock-based compensation 14.5   11.9   28.6   24.0 
Foreign currency transaction gains, net    (1.1)  (0.7)  (0.1)
Loss (income) on equity method investments 3.5   (2.4)  14.2   (2.7)
Loss on extinguishment of debt 3.0   0.9   3.0   0.9 
Adjustments to LIFO inventories 0.4   6.5   7.2   14.3 
Cybersecurity incident costs (0.1)  2.2   0.5   2.2 
Loss on asbestos sale 58.8      58.8    
Interest income on cash and cash equivalents (16.3)  (6.1)  (27.7)  (10.8)
Other adjustments       0.4   (1.4)
Adjusted EBITDA$494.6  $424.7  $953.1  $824.8 
Minus:       
Interest expense 50.8   40.8   87.6   79.7 
Income tax provision, as adjusted 92.3   87.9   178.7   163.5 
Depreciation expense 24.6   21.3   49.3   42.0 
Amortization of non-acquisition related intangible assets 2.1   2.6   4.2   5.2 
Interest income on cash and cash equivalents (16.3)  (6.1)  (27.7)  (10.8)
Adjusted Net Income$341.1  $278.2  $661.0  $545.2 
        
Free Cash Flow:       
Cash flows from operating activities$304.9  $228.4  $466.5  $398.7 
Minus:       
Capital expenditures 21.8   24.8   84.1   47.2 
Free Cash Flow$283.1  $203.6  $382.4  $351.5 


INGERSOLL RAND INC. AND SUBSIDIARIES
RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO NET INCOME
(Unaudited; in millions)

 For the Three Month Period
Ended June 30,
 For the Six Month Period
Ended June 30,
  2024   2023   2024   2023 
Orders       
Industrial Technologies and Services$1,465.4  $1,444.3  $2,863.8  $2,894.6 
Precision and Science Technologies 334.0   293.1   643.0   619.6 
Total Orders$1,799.4  $1,737.4  $3,506.8  $3,514.2 
Revenue       
Industrial Technologies and Services$1,466.5  $1,378.4  $2,839.9  $2,695.6 
Precision and Science Technologies 338.8   308.1   635.5   620.2 
Total Revenue$1,805.3  $1,686.5  $3,475.4  $3,315.8 
Segment Adjusted EBITDA       
Industrial Technologies and Services$436.2  $377.5  $847.3  $723.1 
Precision and Science Technologies 102.5   90.0   193.9   184.5 
Total Segment Adjusted EBITDA$538.7  $467.5  $1,041.2  $907.6 
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes:       
Corporate expenses not allocated to segments$44.1  $42.8  $88.1  $82.8 
Interest expense 50.8   40.8   87.6   79.7 
Depreciation and amortization expense 115.8   111.0   232.1   224.1 
Restructuring and related business transformation costs 3.9   5.9   14.6   10.2 
Acquisition and other transaction related expenses and non-cash charges 27.7   13.8   43.0   31.8 
Stock-based compensation 14.5   11.9   28.6   24.0 
Foreign currency transaction gains, net    (1.1)  (0.7)  (0.1)
Loss on extinguishment of debt 3.0   0.9   3.0   0.9 
Adjustments to LIFO inventories 0.4   6.5   7.2   14.3 
Cybersecurity incident costs (0.1)  2.2   0.5   2.2 
Loss on asbestos sale 58.8      58.8    
Interest income on cash and cash equivalents (16.3)  (6.1)  (27.7)  (10.8)
Other adjustments       0.4   (1.4)
Income Before Income Taxes 236.1   238.9   505.7   449.9 
Provision for income taxes 46.1   60.5   100.5   108.6 
Income (loss) on equity method investments (3.5)  2.4   (14.2)  2.7 
Net Income$186.5  $180.8  $391.0  $344.0 


INGERSOLL RAND INC. AND SUBSIDIARIES
ORDERS GROWTH (DECLINE) BY SEGMENT1

 For the Three Month
Period Ended June 30,
 Two-Year
Stack
2
 2024  2023  
Ingersoll Rand     
Organic growth (decline)(1.2%) 4.6% 3.4%
Impact of foreign currency(0.9%) (1.3%) (2.2%)
Impact of acquisitions5.7% 5.4% 11.1%
Total orders growth (decline)3.6% 8.7% 12.3%
      
Industrial Technologies & Services     
Organic growth (decline)(2.6%) 8.2% 5.6%
Impact of foreign currency(1.0%) (1.4%) (2.4%)
Impact of acquisitions5.1% 6.0% 11.1%
Total orders growth (decline)1.5% 12.8% 14.3%
      
Precision & Science Technologies     
Organic growth (decline)5.8% (10.2%) (4.4%)
Impact of foreign currency(0.7%) (0.7%) (1.4%)
Impact of acquisitions8.9% 3.0% 11.9%
Total orders decline14.0% (7.9%) 6.1%

1 Organic growth/(decline), impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period.
2 Two-year stack is defined as the sum of current year growth/(decline) and prior year growth/(decline).


INGERSOLL RAND INC. AND SUBSIDIARIES
REVENUE GROWTH (DECLINE) BY SEGMENT1

 For the Three Month
Period Ended June 30,
 Two-Year
Stack
2
 2024  2023  
Ingersoll Rand     
Organic growth1.0% 12.4% 13.4%
Impact of foreign currency(0.9%) (1.2%) (2.1%)
Impact of acquisitions6.9% 5.9% 12.8%
Total revenue growth7.0% 17.1% 24.1%
      
Industrial Technologies & Services     
Organic growth1.4% 14.4% 15.8%
Impact of foreign currency(0.9%) (1.4%) (2.3%)
Impact of acquisitions5.9% 6.8% 12.7%
Total revenue growth6.4% 19.8% 26.2%
      
Precision & Science Technologies     
Organic growth (decline)(1.1%) 4.6% 3.5%
Impact of foreign currency(0.6%) (0.6%) (1.2%)
Impact of acquisitions11.7% 2.5% 14.2%
Total revenue growth (decline)10.0% 6.5% 16.5%

1 Organic growth/(decline), impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period.
2 Two-year stack is defined as the sum of current year growth/(decline) and prior year growth/(decline).


FAQ

What were Ingersoll Rand's (IR) key financial results for Q2 2024?

Ingersoll Rand (IR) reported Q2 2024 revenues of $1,805 million (up 7% YoY), adjusted EBITDA of $495 million (up 16% YoY), and adjusted EPS of $0.83. Free cash flow increased 39% to $283 million.

Has Ingersoll Rand (IR) updated its guidance for 2024?

Yes, Ingersoll Rand (IR) raised its full-year 2024 guidance. The company now projects total revenue growth of 6-8%, adjusted EBITDA of $2,010-$2,060 million (up 12-15% YoY), and adjusted EPS of $3.27-$3.37 (up 10-14% YoY).

What major acquisition did Ingersoll Rand (IR) complete in Q2 2024?

In Q2 2024, Ingersoll Rand (IR) completed the acquisition of ILC Dover, a specialized manufacturer of innovative market-leading powder management and liquid handling products for biopharma and pharma markets, for $2.6 billion.

How did Ingersoll Rand's (IR) Industrial Technologies and Services segment perform in Q2 2024?

Ingersoll Rand's (IR) Industrial Technologies and Services segment reported Q2 2024 revenues of $1,467 million, up 6% YoY, with Segment Adjusted EBITDA of $436 million, up 16% YoY. The segment's Adjusted EBITDA margin improved by 230 basis points to 29.7%.

Ingersoll Rand Inc.

NYSE:IR

IR Rankings

IR Latest News

IR Stock Data

36.90B
402.18M
0.2%
101.03%
2.3%
Specialty Industrial Machinery
General Industrial Machinery & Equipment
Link
United States of America
DAVIDSON